Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-03-16

FDA Approved: METFORMIN ER 500 MG — Original Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approved Quallent Pharmaceuticals Health LLC's metformin extended-release tablets (500 mg and 750 mg) under ANDA 209313 for type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN ER 500 MG (METFORMIN ER 500 MG)
  • METFORMIN ER 750 MG (METFORMIN ER 750 MG)

Snippet

ORIG AP for METFORMIN ER 500 MG (METFORMIN ER 500 MG)